Danish Medicines Council delays use of QALY to 2021
New drugs will no longer be evaluated using a new method from October onwards. Pressure on the council and its professional advisors mean that the implementation of the new methods has been postponed until January 1, 2021.
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY CATHERINE BRETT
The Danish Medicines Council will keep using its current methods to evaluate treatments for a while yet.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
.jpg&w=384&q=75){kind=logo}
